| Literature DB >> 29773649 |
Shilpee Sharma1, Prabhu S Arunachalam1, Malini Menon1, Viswanath Ragupathy2, Ravi Vijaya Satya3, Joshua Jebaraj1, Shambhu Ganeshappa Aralaguppe1, Chaitra Rao1, Sreshtha Pal1, Shanmugam Saravanan4, Kailapuri G Murugavel4, Pachamuthu Balakrishnan4, Suniti Solomon4, Indira Hewlett2, Udaykumar Ranga5.
Abstract
HIV-1 subtype C (HIV-1C) may duplicate longer amino acid stretches in the p6 Gag protein, leading to the creation of an additional Pro-Thr/Ser-Ala-Pro (PTAP) motif necessary for viral packaging. However, the biological significance of a duplication of the PTAP motif for HIV-1 replication and pathogenesis has not been experimentally validated. In a longitudinal study of two different clinical cohorts of select HIV-1 seropositive, drug-naive individuals from India, we found that 8 of 50 of these individuals harbored a mixed infection of viral strains discordant for the PTAP duplication. Conventional and next-generation sequencing of six primary viral quasispecies at multiple time points disclosed that in a mixed infection, the viral strains containing the PTAP duplication dominated the infection. The dominance of the double-PTAP viral strains over a genetically similar single-PTAP viral clone was confirmed in viral proliferation and pairwise competition assays. Of note, in the proximity ligation assay, double-PTAP Gag proteins exhibited a significantly enhanced interaction with the host protein tumor susceptibility gene 101 (Tsg101). Moreover, Tsg101 overexpression resulted in a biphasic effect on HIV-1C proliferation, an enhanced effect at low concentration and an inhibitory effect only at higher concentrations, unlike a uniformly inhibitory effect on subtype B strains. In summary, our results indicate that the duplication of the PTAP motif in the p6 Gag protein enhances the replication fitness of HIV-1C by engaging the Tsg101 host protein with a higher affinity. Our results have implications for HIV-1 pathogenesis, especially of HIV-1C.Entities:
Keywords: Gag; HIV-1C; NGS; PTAP duplication; Replication advantage; human immunodeficiency virus (HIV); infectious disease; viral DNA; viral protein; viral replication
Mesh:
Substances:
Year: 2018 PMID: 29773649 PMCID: PMC6066301 DOI: 10.1074/jbc.M117.815829
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157